ONYX PHARMACEUTICALS INC Debt Instrument, Fair Value Disclosure
ONYX PHARMACEUTICALS INC had Debt Instrument, Fair Value Disclosure of $421.90 million as of 2012-06-30, per its 10-Q filed 2012-08-06.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2012-08-06
- 2012-06-30: Debt Instrument, Fair Value Disclosure $421.90M.
- 2012-03-31: Debt Instrument, Fair Value Disclosure $289.40M.
- 2011-12-31: Debt Instrument, Fair Value Disclosure $230.00M.
- 2011-09-30: Debt Instrument, Fair Value Disclosure $257.60M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2012-06-30 | $421.90M 10-Q · filed 2012-08-06 |
| 2012-03-31 | $289.40M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $230.00M 10-K · filed 2012-02-27 |
| 2011-09-30 | $257.60M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $271.40M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $230.00M 10-K · filed 2012-02-27 |